ResDTA: Predicting Drug-Target Binding Affinity Using Residual Skip Connections
The discovery of novel drug target (DT) interactions is an important step in the drug development process. The majority of computer techniques for predicting DT interactions have focused on binary classification, with the goal of determining whether or not a DT pair interacts. Protein ligand interactions, on the other hand, assume a continuous range of binding strength values, also known as binding affinity, and forecasting this value remains a difficulty. As the amount of affinity data in DT knowledge-bases grows, advanced learning techniques such as deep learning architectures can be used to predict binding affinities. In this paper, we present a deep-learning-based methodology for predicting DT binding affinities using just sequencing information from both targets and drugs. The results show that the proposed deep learning-based model that uses the 1D representations of targets and drugs is an effective approach for drug target binding affinity prediction and it does not require additional chemical domain knowledge to work with. The model in which high-level representations of a drug and a target are constructed via CNNs that uses residual skip connections and also with an additional stream to create a high-level combined representation of the drug-target pair achieved the best Concordance Index (CI) performance in one of the largest benchmark datasets, outperforming the recent state-of-the-art method AttentionDTA and many other machine-learning and deep-learning based baseline methods for DT binding affinity prediction that uses the 1D representations of targets and drugs.
Code (0)
등록된 구현이 없습니다.
Tasks
Binary ClassificationDeep LearningSimilar Papers 제목 키워드 기반
Drug-target affinity prediction method based on consistent expression of heterogeneous data
The first step in drug discovery is finding drug molecule moieties with medicinal activity against specific targets. Therefore, it is crucial to investigate the interaction between drug-target proteins and small chemical…
Drug DiscoveryDeepDTA: Deep Drug-Target Binding Affinity Prediction
The identification of novel drug-target (DT) interactions is a substantial part of the drug discovery process. Most of the computational methods that have been proposed to predict DT interactions have focused on binary c…
Binary ClassificationDrug DiscoveryPredictionBinding Affinity Prediction: From Conventional to Machine Learning-Based Approaches
Protein-ligand binding is the process by which a small molecule (drug or inhibitor) attaches to a target protein. The binding affinity, which refers to the strength of this interaction, is central to many important probl…
Drug DesignDrug DiscoveryMLT-LE: predicting drug-target binding affinity with multi-task residual neural networks
Assessing drug-target affinity is a critical step in the drug discovery and development process, but to obtain such data experimentally is both time consuming and expensive. For this reason, computational methods for pre…
Drug DiscoveryMulti-Task LearningPredictionGDGRU-DTA: Predicting Drug-Target Binding Affinity Based on GNN and Double GRU
The work for predicting drug and target affinity(DTA) is crucial for drug development and repurposing. In this work, we propose a novel method called GDGRU-DTA to predict the binding affinity between drugs and targets, w…
Time SeriesTime Series Analysis